Home > Insider Trading > Filing (0001140361-16-060226)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380956	Robert Kramer	400 Professional Dr, Suite 400 Gaithersburg MD 20879	Evp, Corporate Services Divisi	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-04-04	5,766	$14.41	80,597	No	4	M	Direct
Common Stock	Disposition	2016-04-04	5,766	$36.90	74,831	No	4	S	Direct
Common Stock	Acquisiton	2016-04-04	1,970	$14.67	76,801	No	4	M	Direct
Common Stock	Disposition	2016-04-04	1,970	$36.90	74,831	No	4	S	Direct
Common Stock	Acquisiton	2016-04-04	8,677	$28.09	83,508	No	4	M	Direct
Common Stock	Disposition	2016-04-04	8,677	$36.90	74,831	No	4	S	Direct
Common Stock	Acquisiton	2016-04-04	2,752	$29.00	77,583	No	4	M	Direct
Common Stock	Disposition	2016-04-04	2,752	$36.90	74,831	No	4	S	Direct
Common Stock	Disposition	2016-04-04	2,623	$36.90	72,208	No	4	S	Direct
Common Stock	Disposition	2016-03-11	422	$34.22	71,786	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2016-04-04	5,766	$0.00	5,766	$14.41
Common Stock	Stock Option	Acquisiton	2016-04-04	1,970	$0.00	1,970	$14.67
Common Stock	Stock Option	Acquisiton	2016-04-04	8,677	$0.00	8,677	$28.09
Common Stock	Stock Option	Acquisiton	2016-04-04	2,752	$0.00	2,752	$29.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,765	2019-11-04	No	4	M	Direct
1,970	2020-03-11	No	4	M	Direct
26,031	2021-03-10	No	4	M	Direct
24,762	2022-03-09	No	4	M	Direct

Footnotes

Consists of an option granted under the company's stock incentive plan on November 5, 2012.
Consists of an option granted under the company's stock incentive plan on March 12, 2013.
Consists of an option granted under the company's stock incentive plan on March 11, 2014.
Consists of an option granted under the company's stock incentive plan on March 10, 2015.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer.
Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
The option vested in three equal installments in November 2013, 2014 and 2015.
The option vest in three equal installments in March 2014, 2015 and 2016.
The option vest in three equal installments in March 2015, 2016 and 2017.
The option vest in three equal installments in March 2016, 2017 and 2018.